🇺🇸 FDA
Patent

US 9149542

Microvesicles derived from cell protoplast and use thereof

granted A61KA61K2039/55555A61K38/162

Quick answer

US patent 9149542 (Microvesicles derived from cell protoplast and use thereof) held by Aeon Medix Inc. expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aeon Medix Inc.
Grant date
Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/55555, A61K38/162, A61K38/1825, A61K38/1866